TY  - JOUR
AU  - Bermejo, Javier
AU  - Yotti, Raquel
AU  - García-Orta, Rocío
AU  - Sánchez-Fernández, Pedro L
AU  - Castaño, Mario
AU  - Segovia-Cubero, Javier
AU  - Escribano-Subías, Pilar
AU  - San Román, José Alberto
AU  - Borrás, Xavier
AU  - Alonso-Gómez, Angel
AU  - Botas, Javier
AU  - Crespo-Leiro, María G
AU  - Velasco, Sonia
AU  - Bayés-Genís, Antoni
AU  - López, Amador
AU  - Muñoz-Aguilera, Roberto
AU  - de Teresa, Eduardo
AU  - González-Juanatey, José R
AU  - Evangelista, Arturo
AU  - Mombiela, Teresa
AU  - González-Mansilla, Ana
AU  - Elízaga, Jaime
AU  - Martín-Moreiras, Javier
AU  - González-Santos, José M
AU  - Moreno-Escobar, Eduardo
AU  - Fernández-Avilés, Francisco
AU  - Sildenafil for Improving Outcomes after VAlvular Correction (SIOVAC) investigators
PY  - 2018
DO  - 10.1093/eurheartj/ehx700
UR  - http://hdl.handle.net/10668/11954
T2  - European heart journal
AB  - We aimed to determine whether treatment with sildenafil improves outcomes of patients with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD). The sildenafil for improving outcomes after valvular correction...
LA  - en
KW  - Aged
KW  - Double-Blind Method
KW  - Female
KW  - Heart Failure
KW  - Heart Valve Diseases
KW  - Humans
KW  - Hypertension, Pulmonary
KW  - Male
KW  - Placebos
KW  - Pulmonary Wedge Pressure
KW  - Sildenafil Citrate
KW  - Treatment Outcome
KW  - Vasodilator Agents
TI  - Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
TY  - research article
VL  - 39
ER  -